Skip navigation

Improve Access and Outcomes Across the Care Continuum

March 2-4, 2020
  • Philadelphia, PA

CBI’s 5th Annual IDN and BioPharma Partnering Summit serves as a think-tank for industry pioneers to discuss the current state of affairs and latest collaborations by showcasing novel case studies and pilot programs that enhance care continuity, examine the patient journey and improve overall patient outcomes.

NEW, CAN’T-MISS FEATURES FOR 2020:

  • Benefit from three in-depth workshops examining:
    1. Population Health Management
    2. Specialty Pharmacy Integration
    3. Contracting with Employers
  • Attend an Extended Think Tank Session for a 360-degree view
    on risk-based agreements
  • Hear a Product Mix Showcase covering critical therapeutic
    areas, such as cell/gene therapies, biosimilars, RA, HCV,
    chronic diseases and oncology
  • Gain critical insights from industry’s foremost thought-leaders
    and stakeholders across the care continuum

DISCUSS INNOVATIVE PARTNERSHIP MODELS, COMPARE POPULATION HEALTH MANAGEMENT STRATEGIES AND...

  • Explore employer trends in cost sharing, utilization management, pharmacy network strategy and more
  • Map the patient care pathway and stakeholder roles
  • Assess the value of an integrated health system with care delivery, health plans and pharmacies impacting total cost of care
  • Gain insight on how manufacturers can illustrate the value of working with IDNs to executive leadership
  • Consider engagement strategies for risk-based contracting
    with evolving IDNs
  • Examine the different approaches to IDN-SP integration and how manufacturers can utilize this information for strategic planning
  • Describe the benefits of collaboration across the industry to optimize and standardize outcomes reporting
  • Uncover leading strategies for driving successful
    collaborations with providers
  • Analyze the legal perspectives on optimizing
    pharma/IDN partnerships

TOP 5 REASONS TO ATTEND CBI’s
IDN and BioPharma Partnering Summit:

Download the Conference Preview

Previous Attendee Acclaim:

Always get so much out of these sessions and
they get better every time.

Senior Manager, Commercial Excellence, Sanofi

Most informative and collaborative conference I’ve been to in years. It is one of the most thought-provoking events. Thank you so much for all your hard work and attention
to quality of content and speakers.

Founding Partner, Blue Fin Group

Well organized and good speaker selection.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The knowledge base and experience of the attendees exceeded my expectations. The conference truly was a working session more than a speaker’s conference.

Principal/Chief Operating Officer, Curant Health

The conference helped me understand the needs for all stakeholders. Manufacturers and IDNS can help each other and improve outcomes for patients as specialty drugs continue to grow as a percentage of pharmacy budgets.

Senior Director, Acentrus

Some of the biggest changes in the healthcare space are occurring around IDNs, ACOs and payers. This is a dynamic part of the market and this conference provides relevant content and perspectives surrounding it.

Head of Global MDM, Lexis Nexis

5th Annual IDN and BioPharma Partnering Summit

Improve Access and Outcomes Across the Care Continuum

CBI’s 5th Annual IDN and BioPharma Partnering Summit serves as a think-tank for industry pioneers to discuss the current state of affairs and latest collaborations by showcasing novel case studies and pilot programs that enhance care continuity, examine the patient journey and improve overall patient outcomes.

NEW, CAN’T-MISS FEATURES FOR 2020:

  • Benefit from three in-depth workshops examining:
    1. Population Health Management
    2. Specialty Pharmacy Integration
    3. Contracting with Employers
  • Attend an Extended Think Tank Session for a 360-degree view
    on risk-based agreements
  • Hear a Product Mix Showcase covering critical therapeutic
    areas, such as cell/gene therapies, biosimilars, RA, HCV,
    chronic diseases and oncology
  • Gain critical insights from industry’s foremost thought-leaders
    and stakeholders across the care continuum

DISCUSS INNOVATIVE PARTNERSHIP MODELS, COMPARE POPULATION HEALTH MANAGEMENT STRATEGIES AND...

  • Explore employer trends in cost sharing, utilization management, pharmacy network strategy and more
  • Map the patient care pathway and stakeholder roles
  • Assess the value of an integrated health system with care delivery, health plans and pharmacies impacting total cost of care
  • Gain insight on how manufacturers can illustrate the value of working with IDNs to executive leadership
  • Consider engagement strategies for risk-based contracting
    with evolving IDNs
  • Examine the different approaches to IDN-SP integration and how manufacturers can utilize this information for strategic planning
  • Describe the benefits of collaboration across the industry to optimize and standardize outcomes reporting
  • Uncover leading strategies for driving successful
    collaborations with providers
  • Analyze the legal perspectives on optimizing
    pharma/IDN partnerships

TOP 5 REASONS TO ATTEND CBI’s
IDN and BioPharma Partnering Summit:

Download the Conference Preview

Previous Attendee Acclaim:

Always get so much out of these sessions and
they get better every time.

Senior Manager, Commercial Excellence, Sanofi

Most informative and collaborative conference I’ve been to in years. It is one of the most thought-provoking events. Thank you so much for all your hard work and attention
to quality of content and speakers.

Founding Partner, Blue Fin Group

Well organized and good speaker selection.

Assistant Director, Specialty Pharmacy Services, University of Illinois

The knowledge base and experience of the attendees exceeded my expectations. The conference truly was a working session more than a speaker’s conference.

Principal/Chief Operating Officer, Curant Health

The conference helped me understand the needs for all stakeholders. Manufacturers and IDNS can help each other and improve outcomes for patients as specialty drugs continue to grow as a percentage of pharmacy budgets.

Senior Director, Acentrus

Some of the biggest changes in the healthcare space are occurring around IDNs, ACOs and payers. This is a dynamic part of the market and this conference provides relevant content and perspectives surrounding it.

Head of Global MDM, Lexis Nexis